July 29, 2025 - 05:02

ALAMEDA, Calif., July 28, 2025--Exelixis, Inc. has announced its financial results for the second quarter of 2025, highlighting significant achievements and advancements in its corporate objectives. The company outlined its ongoing commitment to innovation, detailing progress in both commercial operations and clinical development.
In the second quarter, Exelixis reported robust financial performance, reflecting growth in revenue streams driven by its key product offerings. The company emphasized its strategic focus on enhancing patient access to its therapies, which has been pivotal in driving sales.
Additionally, Exelixis provided insights into its clinical pipeline, showcasing advancements in key studies and potential new indications for existing therapies. The company remains dedicated to expanding its research efforts, with several upcoming milestones set for the remainder of the year.
Overall, Exelixis continues to strengthen its position in the biopharmaceutical landscape, aiming to deliver innovative treatments to patients while achieving sustainable growth.
February 5, 2026 - 05:06
AccountAbility Appoints Guillaume Mascotto as Director of Advisory ServicesAccountAbility, a leading global consulting and standards firm, has announced a key addition to its leadership team. Guillaume Mascotto has been appointed as the firm`s new Director of Advisory...
February 4, 2026 - 05:28
How 'second guessing' cost high earning Aussie couple more than $200,000Financial indecision has proven to be a remarkably expensive habit for one high-earning Australian couple, whose reluctance to act cost them a staggering sum exceeding two hundred thousand dollars....
February 3, 2026 - 21:42
Sheinbaum doubles down on Plan México, committing 5.6 trillion pesos to major projectsPresident Claudia Sheinbaum has firmly committed to continuing the strategic infrastructure initiative known as Plan México, announcing a monumental financial package totaling 5.6 trillion pesos....
February 3, 2026 - 04:21
AMD Q4 earnings: What Wall Street expects from AI chipmakerAll eyes are on Advanced Micro Devices as the semiconductor giant prepares to unveil its fourth-quarter financial performance. The report, scheduled for release after the closing bell on Tuesday,...